Employing Noble Metal–Porphyrins to Engineer Robust and Highly Active Single‐Atom Nanozymes for Targeted Catalytic Therapy in Nasopharyngeal Carcinoma
Advanced Materials · 2024
DOI: 10.1002/adma.202310033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Daji Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nanozyme Synthesis Center, Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced…. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Chinese Academy of Sciences Project for Young Scientists in Basic Research.
Abstract (Originalsprache)
Single‐atom nanozymes (SANzymes) emerge as promising alternatives to conventional enzymes. However, chemical instability limits their application. Here, a systematic synthesis of highly active and stable SANzymes is presented by leveraging noble metal–porphyrins. Four noble metal–porphyrins are successfully synthesized to mimic the active site of natural peroxidases through atomic metal–N coordination anchored to the porphyrin center. These noble metal–porphyrins are integrated into a stable and biocompatible Zr‐based metal–organic framework (M x P, x denoting Ir, Ru, Pt, and Pd). Among these, MIrP demonstrates superior peroxidase‐like activity (685.61 U mg −1 ), catalytic efficiency, and selectivity compared to horseradish peroxidase (267.71 U mg −1 ). Mechanistic investigations unveil heightened catalytic activity of MIrP arises from its robust H 2 O 2 adsorption capacity, unique rate‐determining step, and low energy threshold. Crucially, MIrP exhibits remarkable chemical stability under both room temperature and high H 2 O 2 concentrations. Further, through modification with (−)‐Epigallocatechin‐3‐Gallate, a natural ligand for Epstein–Barr virus (EBV)‐encoded latent membrane protein 1, targeted SANzyme (MIrPHE) tailored for EBV‐associated nasopharyngeal carcinoma is engineered. This study not only presents an innovative strategy for augmenting the catalytic activity and chemical stability of SANzymes but also highlights the substantial potential of MIrP as a potent nanomedicine for targeted catalytic tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanozyme Synthesis Center, Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
- Shenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518035, China.
- College of Chemistry and Chemical Engineering, Jiangxi Normal University, Nanchang, 330022, China.
- Department of Otolaryngology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, 518020, China.
- CAS Engineering Laboratory for Nanozyme, Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
- Nanozyme Medical Center, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
ORCID-Profile: Kelong Fan
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Chinese Academy of Sciences Project for Young Scientists in Basic Research
- Natural Science Foundation of Guangdong Province
- Science and Technology Program for Basic Research in Shenzhen
- Medical science and technology research in Guangdong Province
- Sanming Project of Medicine in Shenzen Municipality
- National Basic Research Program of China
Zitieren
APA
Wang, D., Wang, J., Gao, X. J., Ding, H., Yang, M., He, Z., Xie, J., Zhang, Z., Huang, H., Nie, G., Yan, X., & Fan, K. (2024). Employing Noble Metal–Porphyrins to Engineer Robust and Highly Active Single‐Atom Nanozymes for Targeted Catalytic Therapy in Nasopharyngeal Carcinoma. Advanced Materials. https://doi.org/10.1002/adma.202310033
Vancouver
Wang D, Wang J, Gao XJ, Ding H, Yang M, He Z, et al. Employing Noble Metal–Porphyrins to Engineer Robust and Highly Active Single‐Atom Nanozymes for Targeted Catalytic Therapy in Nasopharyngeal Carcinoma. Advanced Materials. 2024. doi:10.1002/adma.202310033
BibTeX
@article{Wang2024,
author = {Wang, Daji and Wang, Jie and Gao, Xuejiao J and Ding, Hui and Yang, Ming and He, Zhiheng and Xie, Jiaying and Zhang, Zixia and Huang, Haibing and Nie, Guohui and Yan, Xiyun and Fan, Kelong},
title = {Employing Noble Metal–Porphyrins to Engineer Robust and Highly Active Single‐Atom Nanozymes for Targeted Catalytic Therapy in Nasopharyngeal Carcinoma},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202310033}
}
EUVIMED